1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Stella Diagnostics Inc (PK) (SLDX)
  7. Quote

SLDX SLDX

Stella Diagnostics (PK) Stock Price

0.67
0.00 (0.0%)
0.67
Volume 32
Bid Price 0.65
Ask Price 0.80
News -
Day High

Low
0.352

52 Week Range

High
1.90

Day Low
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Stella Diagnostics Inc (PK) SLDX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.67 08:45:33
Open Price Low Price High Price Close Price Prev Close
0.67
Trades Volume Avg Volume 52 Week Range
2 32 - 0.352 - 1.90
Last Trade Time Type Quantity Stock Price Currency
09:30:06 12 $ 0.65 USD

Period:

Draw Mode:

Stella Diagnostics Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 65.36M 97.55M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
62.00 $ - - - -

more financials information »

Stella Diagnostics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SLDX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.670.670.670.672000.000.0%
1 Month0.650.670.650.65684932920.023.08%
3 Months0.5450.810.3520.65458956870.12522.94%
6 Months0.7511.150.3520.7153123942-0.081-10.79%
1 Year0.721.900.3520.97167811,668-0.05-6.94%
3 Years0.721.900.3520.97167811,668-0.05-6.94%
5 Years0.721.900.3520.97167811,668-0.05-6.94%

Stella Diagnostics (PK) Description

Stella Diagnostics, Inc. is a molecular diagnostics-based organization focused on improving patient management strategies for over 67 million people living with severe esophageal disease. Stella Diagnostic's mass spec proteomic assays will offer physicians insight into the molecular properties of their patients' tissue to determine if the disease is stable, progressing or turning cancerous. Stella Diagnostics aims to offer a first-line diagnostic tool that provides superior molecular information for providers as compared to the current standard screening protocols.


Your Recent History
USOTC
SLDX
Stella Dia..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.